NCT00056498View on ClinicalTrials.gov

Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Schizophrenia
Interventions
DRUG

Placebo

Placebo capsule daily for 16 weeks

DRUG

Risperdal

Risperdal 4 mg per day for 16 weeks

Trial Locations (1)

21228

Maryland Psychiatric Research Center, Catonsville

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Ortho-McNeil Janssen Scientific Affairs, LLC

INDUSTRY

lead

University of Maryland, Baltimore

OTHER

NCT00056498 - Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine | Biotech Hunter | Biotech Hunter